Is ADCO CEFOXITIN 2 g registered in South Africa?

ADCO CEFOXITIN 2 g is recorded with registration status “Canceled” in South Africa, registration number 36/20.1.1/0326, based on SAHPRA data.

What is the active ingredient in ADCO CEFOXITIN 2 g?

ADCO CEFOXITIN 2 g contains None.

International reference: 2 US FDA recalls for this ingredient

Lack of sterility assurance (cefoxitin)

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units. (cefoxitin)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in South Africa.

Canceled South Africa · SAHPRA

ADCO CEFOXITIN 2 g

None

36/20.1.1/0326

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.

36/20.1.1/0326

Registration date

2003/07/03

Expiry date

Status

Canceled

Active ingredient

None

Dosage form

Strength

Pack size

Therapeutic class

Manufacturer / MAH

Applicant / LTR

Adcock Ingram Critical Care (Pty) Ltd

Country of origin

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:12:57 · updated 2026-09-23 04:10:46

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.